1-Benzyl-1,2,3,4-tetrahydroisoquinoline (1BnTIQ), an endogenous neurotoxin, induces dopaminergic cell death through apoptosis (Q44462590)

3 December 2017

title

1-Benzyl-1,2,3,4-tetrahydroisoquinoline (1BnTIQ), an endogenous neurotoxin, induces dopaminergic cell death through apoptosis (English)

1 reference

3 December 2017

1 reference

2

Manuchair Ebadi

1 reference

3 December 2017

Shaik Shavali

1

1 reference

3 December 2017

publication date

1 June 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

24

1 reference

3 December 2017

issue

3

1 reference

3 December 2017

page(s)

417-424

1 reference

Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

Progressive alteration of neuronal dopamine transporter activity in a rat injured by an intranigral injection of MPP .

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

Decreased expression of the NADH:ubiquinone oxidoreductase (complex I) subunit 4 in 1-methyl-4-phenylpyridinium -treated human neuroblastoma SH-SY5Y cells

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons.

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

Uptake of MPP( ) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP.

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

Novel Endogenous 1,2,3,4‐Tetrahydroisoquinoline Derivatives: Uptake by Dopamine Transporter and Activity to Induce Parkinsonism

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

Inhibition of dopamine receptors by endogenous amines: binding to striatal receptors and pharmacological effects on locomotor activity

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells.

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

1‐Benzyl‐1,2,3,4‐Tetrahydroisoquinoline as a Parkinsonism‐Inducing Agent: A Novel Endogenous Amine in Mouse Brain and Parkinsonian CSF

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

Chronic administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

MPP( ) increases the vulnerability to oxidative stress rather than directly mediating oxidative damage in human neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

Presence of tetrahydroisoquinoline and 1-methyl-tetrahydro-isoquinoline in foods: Compounds related to Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

Inhibition of [3H]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

Inhibition of mitochondrial respiration by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain in vivo

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

Histochemical detection of apoptosis in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

SKF-38393, a dopamine receptor agonist, attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

A systematic regional study of dopamine and dopamine-derived salsolinol and norsalsolinol levels in human brain areas

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

Isoquinoline neurotoxins in the brain and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

Migration of tetrahydroisoquinoline, a possible parkinsonian neurotoxin, into monkey brain from blood as proved by gas chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

Presence of tetrahydroisoquinoline, a parkinsonism-related compound, in foods

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

Metabolism and brain accumulation of tetrahydroisoquinoline (TIQ) a possible parkinsonism inducing substance, in an animal model of a poor debrisoquine metabolizer

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

Peroxynitrite inactivates the human dopamine transporter by modification of cysteine 342: potential mechanism of neurotoxicity in dopamine neurons.

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

Neuroprotection and dopamine agonists

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

MPTP: a neurotoxin relevant to the pathophysiology of Parkinson's disease. The 1985 George C. Cotzias lecture

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

In vivo hydroxyl radical generation in the striatum following systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice

1 reference

https://api.crossref.org/works/10.1016/S0161-813X(03)50015-9

7 January 2021

10.1016/S0161-813X(03)00015-9

Identifiers

DOI

1 reference

release_gvnk5qctpvawzndqpm43ojb7vm

3 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gvnk5qctpvawzndqpm43ojb7vm

24 November 2022

mapped directly with Wikidata item

1 reference